What the FDA, NIH hearings tell us about drug and health policy under Trump

Pres­i­dent Don­ald Trump’s nom­i­nees for NIH di­rec­tor and FDA com­mis­sion­er sailed through their re­spec­tive con­fir­ma­tion hear­ings this week, fac­ing few dif­fi­cult ques­tions and of­fer­ing few …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.